Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Experimental and Therapeutic Medicine|April 21, 2023
Unknown‑primary neuroendocrine neoplasms diagnosed by short‑acting somatostatin test: Case series in one institutionTsung-Kun Chang, Wei-Chih Su, Yen-Cheng Chen, et al.
Medicina (Kaunas, Lithuania)|December 23, 2023
Real-World Outcomes of First-Line FOLFIRI Plus Bevacizumab with Irinotecan Dose Escalation versus FOLFOXIRI Plus Bevacizumab in <i>BRAF</i>-Mutant Metastatic Colorectal Cancer: The Preliminary Data from a Single-Center Observational StudyHsiang-Lin Tsai, Ching-Wen Huang, Yen-Cheng Chen, et al.
Oncology Research|June 12, 2023
Effects of the number of neoadjuvant therapy cycles on clinical outcomes, safety, and survival in patients with metastatic colorectal cancer undergoing metastasectomyYung-Sung Yeh, Hsiang-Lin Tsai, Yen-Cheng Chen, et al.
Therapeutic Advances in Medical Oncology|October 30, 2025
Efficacy and safety of regorafenib plus FOLFIRI with <i>UGT1A1</i> genotyping-guided irinotecan dose escalation against metastatic colorectal cancer: a multicenter, phase II, open-label, two-arm randomized controlled triaChing-Wen Huang, Yen-Cheng Chen, Tao-Wei Ker, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|November 13, 2021
Cross-talk between EGFR and BMP signals regulates chondrocyte maturation during endochondral ossificationJohn B Lees-Shepard, Kaitlyn Flint, Melanie Fisher, et al.
BMC Pharmacology & Toxicology|October 26, 2017
Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cellsJui-Ting Chang, Yao-Jen Liang, Chia-Yu Hsu, et al.
Frontiers in Oncology|November 16, 2020
Oncological Outcomes of Robotic-Assisted Surgery With High Dissection and Selective Ligation Technique for Sigmoid Colon and Rectal CancerTzu-Chieh Yin, Wei-Chih Su, Po-Jung Chen, et al.
Medicina (Kaunas, Lithuania)|December 24, 2021
BRAF, MEK, and EGFR Triplet Inhibitors as Salvage Therapy in <i>BRAF</i>-Mutated Metastatic Colorectal Cancer-A Case Series Study <i>Target Therapy of</i> BRAF-<i>Mutated mCRC</i>Jen-Hao Yeh, Hsiang-Lin Tsai, Yen-Cheng Chen, et al.
International Journal of Molecular Sciences|August 7, 2021
Low-Molecular-Weight Fucoidan as Complementary Therapy of Fluoropyrimidine-Based Chemotherapy in Colorectal CancerChing-Wen Huang, Yen-Cheng Chen, Tzu-Chieh Yin, et al.
Cancer Management and Research|May 2, 2022
Clinical Outcomes of Patients with Peritoneal Metastasis-Only Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI Through Irinotecan Dose Escalation According to <i>UGT1A1</i> Polymorphism: Compared to Liver Metastasis-Only, and Lung Metastasis-OnlyChing-Chun Li, Tsung-Kun Chang, Yen-Cheng Chen, et al.
Pageof 13